Anti-snake venom activities of extracts and fractions from callus cultures of Sapindus saponaria


Autoria(s): Silva, Marcos L. da; Marcussi, Silvana; Fernandes, Renata S.; Pereira, Paulo S.; Januario, Ana Helena; Franca, Suzelei C.; Silva, Saulo L. da; Soares, Andreimar M.; Lourenco, Miriam V.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

10/10/2013

10/10/2013

01/03/2012

Resumo

Context: Sapindus saponaria L. (Sapindaceae) bark, root, and fruits are used as sedatives and to treat gastric ulcer and also demonstrate diuretic and expectorant effects. Objective: The anti-snake venom properties of callus of S. saponaria are investigated here for the first time. Materials and methods: In vitro cultivated callus of Sapindus saponaria were lyophilized, and the extracts were prepared with different solvents, before submitting to phytochemical studies and evaluation of the anti-ophidian activity. Crude extracts were fractionated by liquid-liquid partition and the fractions were monitored by thin layer chromatography (TLC). Subsequently, anti-ophidian activities were analyzed toward Bothrops jararacussu Lacerda (Viperidae), B. moojeni Hoge (Viperidae), B. alternates Dumeril (Viperidea) and Crotalus durissus terrificus Lineu (Viperidae) venoms and isolated myotoxins and phospholipase A(2) (PLA(2)). Results: Fractions A1, A2 and the extract in MeOH:H2O (9:1) significantly inhibited the toxic and pharmacological activities induced by snake venoms and toxins, when compared to other extracts and fractions. The lethal, clotting, phospholipase, edema-inducing, hemorrhagic and myotoxic activities were partially inhibited by the different extracts and fractions. TLC profiles of the crude extracts (B and C) and fractions (A1 and A2) showed beta-sitosterol and stigmasterol as their main compounds. Stigmasterol exhibited inhibitory effects on enzymatic and myotoxic activities of PLA(2). Discussion and conclusion: Sapindus saponaria extracts and fractions presented anti-ophidian activity and could be used as an adjuvant to serum therapy or for its supplementation, and in addition, as a rich source of potential inhibitors of enzymes involved in several pathophysiological human and animal diseases.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)

Universidade de Ribeirao Preto UNAERP

Universidade de Ribeirao Preto UNAERP

Faculdade de Ciencias Farmaceuticas de Ribeirao PretoUSP

Faculdade de Ciencias Farmaceuticas de Ribeirao Preto-USP

Identificador

PHARMACEUTICAL BIOLOGY, LONDON, v. 50, n. 3, pp. 366-375, MAR, 2012

1388-0209

http://www.producao.usp.br/handle/BDPI/34120

10.3109/13880209.2011.608072

http://dx.doi.org/10.3109/13880209.2011.608072

Idioma(s)

eng

Publicador

INFORMA HEALTHCARE

LONDON

Relação

PHARMACEUTICAL BIOLOGY

Direitos

closedAccess

Copyright INFORMA HEALTHCARE

Palavras-Chave #MEDICINAL PLANTS #SNAKE VENOMS #ANTI-SNAKE VENOM #ANTI-TOXINS #NATURAL INHIBITORS #BASIC PHOSPHOLIPASE A(2) #AQUEOUS EXTRACT #PHARMACOLOGICAL-ACTIVITIES #ANTIOPHIDIAN PROPERTIES #CHEMICAL-MODIFICATIONS #ECLIPTA-PROSTRATA #PLANT-EXTRACTS #BOTHROPS #NEUTRALIZATION #INHIBITION #PLANT SCIENCES #MEDICAL LABORATORY TECHNOLOGY #PHARMACOLOGY & PHARMACY
Tipo

article

original article

publishedVersion